Literature DB >> 8857488

Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease)

E Arbustini, W C Roberts.   

Abstract

Conclusions from this review, based primarily on study of 39 cardiac allografts in place for >2 months, but also on a study of 37 grafts in place for </=2 months, might include the following: (1) allograft vascular disease affects all layers of the epicardial coronary arteries and usually the intramural coronary arteries in the outer one-half of the left ventricular wall; (2) the resulting intimal lesion is relatively uniform, consisting mainly of cellular and acellular fibrous tissue; it is diffuse, affecting all segments of the major and minor epicardial coronary arteries; (3) the degree of resulting luminal narrowing is similar in most 5-mm coronary segments, making coronary angiography hazardous in reliably predicting accurately the degree of luminal narrowing; (4) the extensive adventitial fibrosis and the extensive fibrous tissue infiltration of the subepicardial tissues probably inhibit dilation and remodeling of the epicardial coronary arteries and indeed may constrict them; (5) luminal narrowing of the epicardial coronary arteries after transplantation may be the consequence of both intraluminal lesions and exterior compression from the surrounding fibrous tissue; (6) intraluminal and intralesion thrombus is commonly observed as are multiluminal channels in coronary plaques, suggesting that organization of thrombi plays some role in the progression of post-transplant epicardial coronary disease; (7) the coronary lesions developing after cardiac transplantation are morphologically quite different in composition than those occurring in natural (nontransplantation) atherosclerosis; and (8) inflammatory cellular infiltrates are often extensive in the subepicardial tissues and the infiltrates in this area may be extensive even when interstitial myocardial inflammatory infiltrates are minimal or absent.

Entities:  

Mesh:

Year:  1996        PMID: 8857488     DOI: 10.1016/s0002-9149(96)00427-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  New issues in heart transplantation for heart failure.

Authors:  Michelle M Kittleson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy.

Authors:  Paco E Bravo; Brian A Bergmark; Tomas Vita; Viviany R Taqueti; Ankur Gupta; Sara Seidelmann; Thomas E Christensen; Michael T Osborne; Nishant R Shah; Nina Ghosh; Jon Hainer; Courtney F Bibbo; Meagan Harrington; Fred Costantino; Mandeep R Mehra; Sharmila Dorbala; Ron Blankstein; Akshay Desai; Lynne Stevenson; Michael M Givertz; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2018-01-21       Impact factor: 29.983

3.  In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy.

Authors:  H Hölschermann; R M Bohle; H Zeller; H Schmidt; U Stahl; L Fink; H Grimm; H Tillmanns; W Haberbosch
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

4.  Aortic carboxypeptidase-like protein regulates vascular adventitial progenitor and fibroblast differentiation through myocardin related transcription factor A.

Authors:  Dahai Wang; Nabil Rabhi; Shaw-Fang Yet; Stephen R Farmer; Matthew D Layne
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

Review 5.  Management of the ACC/AHA Stage D patient: cardiac transplantation.

Authors:  Michelle M Kittleson; Jon A Kobashigawa
Journal:  Cardiol Clin       Date:  2013-10-23       Impact factor: 2.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.